<SEC-DOCUMENT>0001104659-23-083568-index.html : 20230724
<SEC-HEADER>0001104659-23-083568.hdr.sgml : 20230724
<ACCEPTANCE-DATETIME>20230724210947
ACCESSION NUMBER:		0001104659-23-083568
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230721
FILED AS OF DATE:		20230724
DATE AS OF CHANGE:		20230724

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Carter Eric G
		CENTRAL INDEX KEY:			0001387660

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40021
		FILM NUMBER:		231106264

	MAIL ADDRESS:	
		STREET 1:		C/O KING PHARMACEUTICALS, INC.
		STREET 2:		501 FIFTH STREET
		CITY:			BRISTOL
		STATE:			TN
		ZIP:			37620

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AEON Biopharma, Inc.
		CENTRAL INDEX KEY:			0001837607
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				853940478
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		5 PARK PLAZA
		STREET 2:		SUITE 1750
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		(949) 354-6499

	MAIL ADDRESS:	
		STREET 1:		5 PARK PLAZA
		STREET 2:		SUITE 1750
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Priveterra Acquisition Corp.
		DATE OF NAME CHANGE:	20201222
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2321918-11_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2321918-11_4seq1.html

Document 1 - RAW XML: tm2321918-11_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>